Ami R Zota1, Ruth J Geller2, Antonia M Calafat3, Cherie Q Marfori4, Andrea A Baccarelli5, Gaby N Moawad4. 1. Department of Environmental and Occupational Health, The George Washington University Milken Institute School of Public Health, Washington, DC. Electronic address: azota@gwu.edu. 2. Department of Environmental and Occupational Health, The George Washington University Milken Institute School of Public Health, Washington, DC. 3. Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia. 4. Department of Obstetrics and Gynecology, The George Washington University, Washington, DC. 5. Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, New York.
Abstract
OBJECTIVES: To examine the association between phthalate exposure and two measures of uterine fibroid burden: diameter of largest fibroid and uterine volume. DESIGN: Pilot, cross-sectional study. SETTING: Academic medical center. PATIENT(S): Fifty-seven premenopausal women undergoing either hysterectomy or myomectomy for fibroids. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): The diameter of the largest fibroid and uterine dimensions were abstracted from medical records. Spot urine samples were analyzed for 14 phthalate biomarkers using mass spectrometry. We estimated associations between fibroid outcomes and individual phthalate metabolites, sum of di(2-ethylhexyl) phthalate metabolites (∑DEHP), and a weighted sum of anti-androgenic phthalate metabolites (∑AA Phthalates) using linear regression, adjusting for age, race/ethnicity, and body mass index. Fibroid outcomes were also examined dichotomously (divided at the median) using logistic regression. RESULTS: Most women were of black ethnicity, overweight or obese, and college educated. In multivariable models, higher levels of mono-hydroxyisobutyl phthalate, monocarboxyoctyl phthalate, monocarboxynonyl phthalate, mono(2-ethylhexyl) phthalate, mono(2-ethyl-5-hydroxyhexyl phthalate) (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), and mono(2-ethyl-5-carboxypentyl) phthalate (MECPP), ∑DEHP, and ∑AA Phthalates were positively associated with uterine volume. Associations were most pronounced for individual DEHP metabolites (MEHHP, MEOHP, MECPP), ∑DEHP, and ∑AA Phthalates. For example, a doubling in ∑DEHP and ∑AA Phthalates was associated with 33.2% (95% confidence interval 6.6-66.5) and 26.8% (95% confidence interval 2.2-57.4) increase in uterine volume, respectively. There were few associations between phthalate biomarkers and fibroid size. CONCLUSIONS: Exposure to some phthalate biomarkers was positively associated with uterine volume, which further supports the hypothesis that phthalate exposures may be associated with fibroid outcomes. Additional studies are needed to confirm these relationships.
OBJECTIVES: To examine the association between phthalate exposure and two measures of uterine fibroid burden: diameter of largest fibroid and uterine volume. DESIGN:Pilot, cross-sectional study. SETTING: Academic medical center. PATIENT(S): Fifty-seven premenopausal women undergoing either hysterectomy or myomectomy for fibroids. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): The diameter of the largest fibroid and uterine dimensions were abstracted from medical records. Spot urine samples were analyzed for 14 phthalate biomarkers using mass spectrometry. We estimated associations between fibroid outcomes and individual phthalate metabolites, sum of di(2-ethylhexyl) phthalate metabolites (∑DEHP), and a weighted sum of anti-androgenic phthalate metabolites (∑AA Phthalates) using linear regression, adjusting for age, race/ethnicity, and body mass index. Fibroid outcomes were also examined dichotomously (divided at the median) using logistic regression. RESULTS: Most women were of black ethnicity, overweight or obese, and college educated. In multivariable models, higher levels of mono-hydroxyisobutyl phthalate, monocarboxyoctyl phthalate, monocarboxynonyl phthalate, mono(2-ethylhexyl) phthalate, mono(2-ethyl-5-hydroxyhexyl phthalate) (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), and mono(2-ethyl-5-carboxypentyl) phthalate (MECPP), ∑DEHP, and ∑AA Phthalates were positively associated with uterine volume. Associations were most pronounced for individual DEHP metabolites (MEHHP, MEOHP, MECPP), ∑DEHP, and ∑AA Phthalates. For example, a doubling in ∑DEHP and ∑AA Phthalates was associated with 33.2% (95% confidence interval 6.6-66.5) and 26.8% (95% confidence interval 2.2-57.4) increase in uterine volume, respectively. There were few associations between phthalate biomarkers and fibroid size. CONCLUSIONS: Exposure to some phthalate biomarkers was positively associated with uterine volume, which further supports the hypothesis that phthalate exposures may be associated with fibroid outcomes. Additional studies are needed to confirm these relationships.
Authors: Eric D Levens; Robert Wesley; Ahalya Premkumar; Wendy Blocker; Lynnette K Nieman Journal: Am J Obstet Gynecol Date: 2009-03-09 Impact factor: 8.661
Authors: Ganesa Wegienka; Donna Day Baird; Irva Hertz-Picciotto; Siobán D Harlow; John F Steege; Michael C Hill; Joel M Schectman; Katherine E Hartmann Journal: Obstet Gynecol Date: 2003-03 Impact factor: 7.661
Authors: Samantha E Serrano; Catherine J Karr; Noah S Seixas; Ruby H N Nguyen; Emily S Barrett; Sarah Janssen; Bruce Redmon; Shanna H Swan; Sheela Sathyanarayana Journal: Int J Environ Res Public Health Date: 2014-06-12 Impact factor: 3.390
Authors: Hyun Jin Kim; Sung Hoon Kim; Young Sang Oh; Seung-Ho Heo; Kang-Hyun Kim; Do Young Kim; Sa Ra Lee; Hee Dong Chae Journal: Reprod Sci Date: 2020-10-09 Impact factor: 3.060
Authors: Phyllis C Leppert; Ayman Al-Hendy; Donna D Baird; Serdar Bulun; William Catherino; Darlene Dixon; Merrick Ducharme; Quaker E Harmon; Friederike L Jayes; Emmanuel Paul; Aymara Mas Perucho; James Segars; Carlos Simón; Elizabeth A Stewart; Jose Teixeira; Andrea Tinelli; Daniel Tschumperlin; Ami R Zota Journal: F S Sci Date: 2020-11-07
Authors: Maya A Wright; Kristen R Moore; Kristen Upson; Donna D Baird; Helen B Chin Journal: J Womens Health (Larchmt) Date: 2021-03-05 Impact factor: 2.681
Authors: Abee L Boyles; Brandiese E Beverly; Suzanne E Fenton; Chandra L Jackson; Anne Marie Z Jukic; Vicki L Sutherland; Donna D Baird; Gwen W Collman; Darlene Dixon; Kelly K Ferguson; Janet E Hall; Elizabeth M Martin; Thaddeus T Schug; Alexandra J White; Kelly J Chandler Journal: J Womens Health (Larchmt) Date: 2020-11-18 Impact factor: 2.681
Authors: Amelia K Wesselink; Jennifer Weuve; Victoria Fruh; Traci N Bethea; Birgit Claus Henn; Quaker E Harmon; Russ Hauser; Paige L Williams; Antonia M Calafat; Michael McClean; Donna D Baird; Lauren A Wise Journal: Fertil Steril Date: 2021-08-05 Impact factor: 7.329
Authors: Victoria Fruh; Birgit Claus Henn; Jennifer Weuve; Amelia K Wesselink; Olivia R Orta; Timothy Heeren; Russ Hauser; Antonia M Calafat; Paige L Williams; Donna D Baird; Lauren A Wise Journal: Environ Int Date: 2020-12-21 Impact factor: 9.621